Luke Nakaji/中島 振一郎 retweeted
サンディエゴで開催された米国コンサルテーション・リエゾン精神医学会(ACLP)年次総会にて、Foundation Research Professor Awardの受賞講演を行いました。
臨床現場での疑問を出発点に、脳波を用いたせん妄検出デバイス(BSEEG)の開発、エピジェネティクスによる病態解明、動物モデルを用いた新規治療薬の探索について、これまでの研究の歩みを紹介しました。
若手の登竜門である2008年のWilliam Webb Fellowship Awardを頂いて以来、ACLPは私にとりホームグラウンドのような学会でしたが、2023年のWayne Katon Research Awardに続く今回の受賞は、大変感慨深いものでした。特に今回の賞に伴い、三名の若手研究者をメンターとしてサポートする役割が与えられ、次世代のために尽力できる喜びと同時に責任を感じています。
長年にわたり支えてくださった恩師、共同研究者、ラボのメンバーに心より感謝します。
UC Irvineでの新たな役割を通じて、せん妄の診断・治療の進歩のために更なる研究を進めると同時に、ラボ内外の次世代の研究者の育成に貢献していきたいと思います。
#ACLP2026 #せん妄 #BSEEG #エピジェネティクス
Luke Nakaji/中島 振一郎 retweeted
How does the brain keep its specialized circuits distinct while still letting them share information? A new review in Nature Reviews Neuroscience from Hong-Wei Dong, Nicholas Foster & Houri Hintiryan of @dgsomucla pulls together the latest wiring maps of the loops linking the cortex, basal ganglia & thalamus. Mapped down to single neurons, these networks show a modular design with overlapping boundaries & feedback loops. That framework gives researchers testable ideas about how circuit architecture shapes behavior & what goes wrong in neurological & psychiatric disorders. A great read for anyone curious how the brain is wired. doi.org/10.1038/s41583-026-0…
Luke Nakaji/中島 振一郎 retweeted
雪の白さと、空の青さ。
季節外れの観光地というのは、どうしてこうも人の心を落ち着かせるのだろう。
#十和田湖
Luke Nakaji/中島 振一郎 retweeted
A groundbreaking @UCSF study from @ChangLabUcsf, published in @ScienceMagazine, identified a subregion of Wernicke's area becomes active before we speak and is necessary for speech production—encoding features of an upcoming word.
神経精神症状各種についての病変ネットワークマッピングの注目度が上がっている。
個人的には、QST主導で、神経変性疾患と老年期精神疾患に対するタウネットワークマッピングによって同定された焦点にTMS治療を行う研究に参加しているので、こういう記事が上がってくると嬉しくなります。
Lesional mania:#躁状態 を引き起こす脳の病変はどこか?―右側頭葉・視床・眼窩前頭皮質の重要性 - 脳卒中や脳腫瘍などに伴う病変性躁状態(lesional mania)211例の解析.右半球病変が圧倒的に多く,特に右側頭葉,海馬,視床,眼窩前頭皮質が重要でした.単一の病変ではなく,情動や行動を制御する神経ネットワークの障害が躁状態を引き起こす可能性があります.pkcdelta.hatenablog.com/entr…
5
362
Luke Nakaji/中島 振一郎 retweeted
Could a simple blood test finally help us diagnose CTE during life? One of the greatest challenges in chronic traumatic encephalopathy (CTE) has been our inability to definitively diagnose the disease while a person is alive. A fascinating new study published in JAMA by Miner and colleagues, accompanied by an important editorial from Palleis and Höglinger, offers a potential breakthrough. Researchers examined blood samples collected during life from 21 former football players who subsequently donated their brains for autopsy; 18 had confirmed CTE. They discovered that a blood biomarker called eMTBR-tau, which reflects abnormal tau protein accumulation, was significantly elevated in individuals with advanced CTE (stages III–IV) compared with those with early-stage disease or no CTE. Importantly, higher levels correlated with greater tau pathology in the brain, even after excluding individuals with coexisting Alzheimer's disease. The commonly used Alzheimer's biomarker p-tau217 did not show the same association with CTE. What resonates with me is the possibility that we may finally be moving from diagnosing CTE after death toward identifying its underlying biology during life. However, the accompanying editorial appropriately reminds us that this was a very small study, with only three participants without CTE, and that Alzheimer's co-pathology complicates interpretation. We still do not know whether this blood test can reliably detect early CTE or distinguish it from other neurodegenerative diseases. This is not yet a diagnostic test ready for clinical practice, but it is an exciting step toward a future in which we can diagnose earlier, develop targeted treatments, and ultimately prevent the devastating consequences of repetitive head impacts.
doi.org/10.1001/jama.2026.24…
doi.org/10.1001/jama.2026.24…
Luke Nakaji/中島 振一郎 retweeted
A region of the brain named Wernicke’s area—long thought to be involved in speech perception—also generates spoken words, according to a new Science study in humans that tackles a century-old debate in the neuroscience of speech.
Learn more: scim.ag/4Cdbw1a
Maintenance ketamine infusions for treatment-resistant bipolar depression: An open-label extension trial: Med cell.com/med/fulltext/S2666-…
Luke Nakaji/中島 振一郎 retweeted
A noninvasive brain stimulation technique called tTIS can modulate reward learning circuits in the brain and safely relieves symptoms of subclinical #depression in adults, according to new results from a clinical trial in @ScienceTM. scim.ag/4zwOkZg
ALSに対するエダラボンの効果に疑問符?―欧州第3相ADORE試験で有効性を確認できず - Lancet Neurology誌に報告された302名の第3相試験では,48週間のALSFRS-R低下に有意差を認めず,生存期間延長も確認されませんでした.日本の過去の陽性試験に近い患者群でも有効性は再現されませんでした.ただし,今回は毎日経口投与であり,日本の承認用法とは異なります.今後の治療選択と協働意思決定に重要な論文です.pkcdelta.hatenablog.com/entr…
Luke Nakaji/中島 振一郎 retweeted
Breaking News: Scientists have discovered a possible marker for CTE, which disproportionately affects athletes in contact sports, raising hopes that a blood test could diagnose the brain disease. nyti.ms/3WUfs6Z
Glad to see our paper introduced on X.
Why does schizophrenia treatment response vary? New neuromelanin MRI study from Psychological Medicine found shared midbrain dopaminergic abnormalities in standard treatment responders & patients w/persistent symptoms despite clozapine. Read article 👉 cup.org/4kURnH1
2023年の加入から怪我での離脱は1度も無し バルセロナに欠かせぬ戦力となったG・マルティンの稼働率(theWORLD(ザ・ワールドWeb))
#Yahooニュース
news.yahoo.co.jp/articles/57…
1
385


































